Liesbeth Ceelen

Liesbeth Ceelen has a diverse range of work experience, primarily in the life science and healthcare industries. Liesbeth is currently serving as the Chief Executive Officer and board member at BioLizard since November 2021, after previously holding roles as General Manager and Director of Business Development at the same company. Liesbeth is also a member of the Board of Directors at RheumaFinder, an AI company specializing in early detection of rheumatoid diseases on medical imaging. Liesbeth has served as an advisory board member at Novalis Biotech Incubation and an associate member at Women on Board Belgium. Liesbeth has also held roles as a task leader at REPO4EU, a director at large for marketing and communications at the Healthcare Businesswomen's Association - Entrepreneurship, a technical auditor at BELAC, and the Chief Business Officer at PATHOMATION. Prior to their current positions, they worked at MindCapture, where they served as head of QM services and senior talent recruiter, as well as in business development and talent recruitment. Additionally, Liesbeth has their own consultancy company, Ceelen Consultancy, where they utilize their expertise in veterinary medicine and life science to provide independent consulting services.

Liesbeth Ceelen obtained a Bachelor's degree in Veterinary Medicine from Universiteit Antwerpen in 2000. Liesbeth then went on to complete their Master's degree in Laboratory Animal Sciences at Ghent University from 2004 to 2006. During the same period, they also earned their PhD in Veterinary Sciences from Ghent University. In 2003, they began their studies at Ghent University, where they obtained a degree as a Veterinarian. Prior to that, they attended Paridaens Instituut Leuven from 1991 to 1997, specializing in Greek and Mathematics. Liesbeth has also completed an Executive Programme for Women Leaders at Vlerick Business School in 2016, and is currently pursuing an Executive MBA from Vlerick Business School, with an expected completion date in 2024. There is no information provided about any additional certifications or when they were obtained.